Why Assuring the Quality of Antimicrobials Is a Global Imperative
AMA Journal of Ethics · 2024
DOI: 10.1001/amajethics.2024.472 ↗Kurz gefasst
Fachartikel in der Zeitschrift AMA Journal of Ethics, 2024. Verfasst von Amy B Cadwallader und 2 weiteren Autor:innen. Beteiligte Einrichtung: Director of regulatory and public policy development at US Pharmacopeia. Hauptthemen laut MEDLINE: Anti-Infective Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients' health and safety, especially in low- and middle-income regions. This article discusses consequences and risks of antimicrobial resistance and other ways in which antimicrobial medicines can be of poor quality and recommends regulatory and policy reforms to help maintain supply chain resilience and quality of antimicrobial medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Director of regulatory and public policy development at US Pharmacopeia.
- Senior advisor on policy and advocacy for Project Hope.
- US Pharmacopeia Quality Institute fellow.
Zitieren
APA
Cadwallader, A. B., Nallathambi, K., & Ching, C. (2024). Why Assuring the Quality of Antimicrobials Is a Global Imperative. AMA Journal of Ethics. https://doi.org/10.1001/amajethics.2024.472
Vancouver
Cadwallader AB, Nallathambi K, Ching C. Why Assuring the Quality of Antimicrobials Is a Global Imperative. AMA Journal of Ethics. 2024. doi:10.1001/amajethics.2024.472
BibTeX
@article{Cadwallader2024,
author = {Cadwallader, Amy B and Nallathambi, Kavitha and Ching, Carly},
title = {Why Assuring the Quality of Antimicrobials Is a Global Imperative},
journal = {AMA Journal of Ethics},
year = {2024},
doi = {10.1001/amajethics.2024.472}
}
EUVIMED